Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

Status:
Terminated

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients with Advanced Multiple Myeloma.

Phase 2

Cephalon